Diversified Healthcare Trust (NASDAQ:DHC) Downgraded by Zacks Research to “Strong Sell”

Diversified Healthcare Trust (NASDAQ:DHC) was downgraded by analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a report released on Thursday,Zacks.com reports.

Several other brokerages also recently issued reports on DHC. Weiss Ratings reiterated a “sell (d-)” rating on shares of Diversified Healthcare Trust in a research note on Wednesday. B. Riley reaffirmed a “buy” rating and issued a $6.50 price objective (up from $5.50) on shares of Diversified Healthcare Trust in a research report on Monday, December 15th. Finally, Royal Bank Of Canada raised Diversified Healthcare Trust from an “underperform” rating to a “sector perform” rating and lifted their target price for the stock from $3.00 to $5.00 in a report on Thursday, November 13th. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Reduce” and an average price target of $5.75.

Diversified Healthcare Trust Trading Down 1.2%

NASDAQ DHC opened at $5.66 on Thursday. Diversified Healthcare Trust has a 12 month low of $2.00 and a 12 month high of $6.06. The company has a current ratio of 16.89, a quick ratio of 16.89 and a debt-to-equity ratio of 1.61. The stock’s fifty day moving average price is $5.03 and its 200-day moving average price is $4.35. The stock has a market cap of $1.37 billion, a P/E ratio of -3.88 and a beta of 2.42.

Diversified Healthcare Trust (NASDAQ:DHC) last posted its quarterly earnings results on Monday, November 3rd. The real estate investment trust reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.08 by ($0.04). Diversified Healthcare Trust had a negative return on equity of 18.90% and a negative net margin of 22.90%.The company had revenue of $388.71 million during the quarter, compared to analysts’ expectations of $382.10 million.

Insider Buying and Selling at Diversified Healthcare Trust

In other news, CEO Christopher J. Bilotto purchased 20,000 shares of the company’s stock in a transaction dated Monday, December 15th. The shares were purchased at an average cost of $4.89 per share, for a total transaction of $97,800.00. Following the purchase, the chief executive officer directly owned 266,285 shares in the company, valued at approximately $1,302,133.65. This represents a 8.12% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 1.37% of the stock is owned by insiders.

Institutional Trading of Diversified Healthcare Trust

A number of hedge funds have recently bought and sold shares of the company. Prudential Financial Inc. grew its stake in shares of Diversified Healthcare Trust by 7.7% during the 2nd quarter. Prudential Financial Inc. now owns 2,129,197 shares of the real estate investment trust’s stock valued at $7,623,000 after purchasing an additional 151,479 shares during the period. Farther Finance Advisors LLC lifted its stake in shares of Diversified Healthcare Trust by 169.2% in the 2nd quarter. Farther Finance Advisors LLC now owns 10,161 shares of the real estate investment trust’s stock worth $36,000 after purchasing an additional 6,387 shares during the period. SG Americas Securities LLC boosted its holdings in shares of Diversified Healthcare Trust by 560.3% in the third quarter. SG Americas Securities LLC now owns 244,211 shares of the real estate investment trust’s stock worth $1,077,000 after buying an additional 207,225 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its holdings in shares of Diversified Healthcare Trust by 22.3% in the second quarter. Arrowstreet Capital Limited Partnership now owns 1,890,628 shares of the real estate investment trust’s stock worth $6,768,000 after buying an additional 345,110 shares during the last quarter. Finally, Geode Capital Management LLC grew its position in Diversified Healthcare Trust by 0.8% during the second quarter. Geode Capital Management LLC now owns 5,847,246 shares of the real estate investment trust’s stock valued at $20,936,000 after buying an additional 44,759 shares during the period. Hedge funds and other institutional investors own 75.98% of the company’s stock.

About Diversified Healthcare Trust

Diversified Healthcare Trust is a real estate investment trust (REIT) specializing in the acquisition, ownership and management of healthcare properties across the United States. The company focuses on assets that serve the senior housing and post-acute care sectors, including skilled nursing facilities, assisted living communities, memory care centers and medical office buildings. By partnering with experienced operators, Diversified Healthcare Trust aims to generate stable, long-term cash flows through triple-net leases and percentage rent structures tailored to each property type.

The company’s portfolio spans multiple states and encompasses a mix of single-tenant and multi-tenant properties.